fdli s introduction to device law and regulation
Download
Skip this Video
Download Presentation
FDLI’s Introduction to Device Law and Regulation

Loading in 2 Seconds...

play fullscreen
1 / 49

FDLI’s Introduction to Device Law and Regulation - PowerPoint PPT Presentation


  • 108 Views
  • Uploaded on

FDLI’s Introduction to Device Law and Regulation. Violations and Enforcement presented by Bradley Merrill Thompson Epstein, Becker & Green PC January 25, 2007. Topics. Part One Inspections Part Two Enforcement Tools Part Three Enforcement Climate. Part One: Inspections.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'FDLI’s Introduction to Device Law and Regulation' - tracey


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
fdli s introduction to device law and regulation

FDLI’s Introduction to Device Law and Regulation

Violations and Enforcement

presented byBradley Merrill Thompson

Epstein, Becker & Green PC

January 25, 2007

topics
Topics

Part One Inspections

Part Two Enforcement Tools

Part Three Enforcement Climate

inspection topics
InspectionTopics

Overview of the Process

Overview of the Law

Having a Plan

overview of the process
Overview of the Process
  • Some reasons for an inspection
    • Routine
    • Directed
    • Follow up
    • Recall effectiveness check
    • Start-up
    • Pre-approval
  • Likelihood of getting inspected
  • Will they call ahead?
  • Use of third parties
  • Remember evidence gathering purpose
overview of the law
Overview of the Law
  • Section 704 defines the permitted scope and nature very generally
  • Greater scrutiny for drugs and restricted devices
  • Special rules on--
    • Sampling
    • Records (e.g. interstate shipment and sales, pricing, personnel and research)
    • Affidavits
    • Oral questions regarding facts
having a plan
Having a Plan
  • Address the following stages:
    • Who greets the investigator and what do they do?
      • Does FDA need a warrant or your consent?
    • Who accepts the Notice of Inspection?
    • Who will host the investigator and what will that host do?
    • How will you determine the reason for the inspection?
    • Will you permit the use of a camera?
      • If not, what will you do if the investigator insists?
having a plan1
Having a Plan
  • More stages—
    • Any limits on when the investigator may inspect?
    • Will the host ever leave the investigator alone?
    • What records and areas may be inspected?
    • What will the host do if the investigator requests samples or an affidavit?
      • Will you charge for samples?
having a plan2
Having a Plan
  • More stages—
    • Who will be at the close out and what will they do? What will you promise?
    • Will you request a copy of the EIR?
    • What will you do after the inspection?
      • How will you respond to any FD 483?
      • How will you respond to any warning letter?
        • Don’t over promise
        • Don’t under promise
having a plan3
Having a Plan
  • Communicate the plan
  • Relationship Management:
    • A question of balance
      • Respect for the law
      • Respect for the agency
enforcement tool topics
Enforcement Tool Topics
  • Prohibited Acts
  • Interstate Commerce Element
  • Agency Remedies
  • Judicial Enforcement
  • FDA’s Choice of Remedies
  • Other Enforcement Activities
  • Preventive Measures
  • Need for Consistency
1 prohibited acts
1. Prohibited Acts
  • Acts of Adulteration or Misbranding on Devices:
    • To be Introduced into Interstate Commerce
    • In Interstate Commerce
    • Held for Sale after Interstate Commerce
1 prohibited acts1
1. Prohibited Acts
  • Other Such Acts
    • Refusing inspection
    • Refusing access to certain documents
    • False guaranty
    • Destroying certain labeling
    • Failure to register an establishment
    • And so on
interstate commerce element
Interstate Commerce Element
  • The Constitution
  • Element of the offense
3 agency remedies
3. Agency Remedies
  • FDA Discretion
    • Section 306
    • Untitled letters
    • Warning Letters
  • Recalls
    • Firm Initiated
    • Agency Initiated
    • Mandatory
  • Civil Penalty
3 agency remedies1
3. Agency Remedies
  • Revocation or Suspension of Approvals
  • Publicity
  • Administrative Detention
  • Banning Devices
  • Notification and Repair, Replacement or Refund
4 judicial enforcement
4. Judicial Enforcement
  • Civil Penalties
  • Seizures and Condemnation
  • Criminal Penalties
    • Strict Liability Without Criminal Intent
    • Repeat Offenses as Felonies
    • Individual Liability and the Park Doctrine
    • Section 305 Hearing
4 judicial enforcement1
4. Judicial Enforcement
  • Injunction
    • Preliminary Injunctions Before Trial
    • Permanent Injunctions and Consent Decrees
    • Continuous FDA Oversight of Operations
5 fda s choice of remedies
5. FDA’s Choice of Remedies
  • Speed
  • Tactical Leverage
  • Degrees of Complexity
  • Cost
  • Burden of Proof
  • Publicity
  • Impact of the Judgment
  • Forum Shopping
6 other enforcement activities
6. Other Enforcement Activities
  • Other Federal Criminal Statutes
        • Conspiracy, 18 U.S.C. § 371
        • False reports, 18 U.S.C. § 1001
        • Mail fraud, 18 U.S.C. § 1341
        • Perjury, 18 U.S.C. § 1623
  • Private Lawsuits
  • States
7 preventive measures
7. Preventive Measures
  • Obtain a Guaranty
  • Effective Program to Prevent and Detect Violations of Law (a.k.a. Compliance Program)
8 need for consistency
8. Need for Consistency

One Company Principle

  • Interpretation A may be okay
  • Interpretation B may be okay
  • But if they differ, one company cannot adopt both A and B
  • Caveat: Different facts warrant different treatment
part three regulatory environment1
Part Three:RegulatoryEnvironment
  • FDA Trends
  • Implications
fda trends
FDA Trends
  • Strategic Goals for CDRH Postmarket Transformation Initiative
    • Create Culture of Collaboration
    • Develop World Class Data Systems
    • Enhance Risk/Benefit Communication Efforts
    • Collaborate on Enforcement Strategies and Outcomes
fda trends1
FDA Trends

CDRH Inspections: Inspections for

Class II & III Domestic Manufacturers

fda trends2
FDA Trends
  • FDA conducted a study of about 300 inspections of medical device manufacturers in FY 2002
    • Characteristics of the inspections
    • Characteristics of the devices inspected
    • Types of QS deficiencies cited in the 483s that were issued
    • Type of action indicated
fda trends3
FDA Trends

FY 2002 Establishment Inspections:

Inspection Characteristics

fda trends4
FDA Trends

FY 2002 Establishment Inspections:

Device Characteristics

fda trends5
FDA Trends

QS/GMP Deficiencies in 483s Issued

fda trends6
FDA Trends

Top 10 Device Observations Used in Turbo EIR (as of 7/2004)

fda trends7
FDA Trends

FY 2002 Establishment Inspections:

District Decisions

fda trends8
FDA Trends

Agency-Wide Warning Letters 1994-2005

slide36
FDA Trends

Warning Letters: Device-related by

Percent of Total Issued

fda trends9
FDA Trends

Warning Letters: Drug-related

by Percent of Total Issued

fda trends10
FDA Trends

Consequences of a Medical Device Inspection

slide44
FDA Trends

Recalls: Agency-Wide 1992-2003

slide46
FDA Trends

Recalls: CDRH 1998-2003

take away points
Take-Away Points
  • Overall, CDRH enforcement environment becoming tougher
  • Shifting focus –labeling , premarket but GMPs remain important
  • Conservation of limited resources may lead to fewer, yet more focused inspections
  • Recalls are steadily increasing
conclusion
Conclusion
  • Consider using metrics to help measure (and manage) your compliance
    • Company boards have an obligation to oversee compliance, but need a meaningful assessment
    • Company management needs to assess the impact of investments in the company’s compliance effort, and to manage risk
    • Company employees need a compliance metric to rally around
  • Metrics can form the basis for useful benchmarking

Our view was, if we could measure it, we could manage it.

Dan England

ad